Emerald Advisors’s Medtronic MDT Stock Holding History

Emerald Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$202K	Buy	+2,335	New	+$224K	0.03%	119
2021 Q4	–	Sell	-4,401	Closed	-$552K	–	105
2021 Q3	$552K	Buy	4,401 +134	+3%	+$17.3K	0.16%	50
2021 Q2	$530K	Buy	4,267 +199	+5%	+$25K	0.17%	52
2021 Q1	$481K	Sell	4,068 -274	-6%	-$32.1K	0.17%	43
2020 Q4	$509K	Buy	+4,342	New	+$478K	0.18%	40
2020 Q1	–	Sell	-2,856	Closed	-$341K	–	96
2019 Q4	$341K	Buy	+2,856	New	+$313K	0.32%	57

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Emerald Advisors's MDT Position: Q1 2026 in Review

Emerald Advisors opened a new position in Medtronic (MDT) in Q1 2026: 2,335 shares worth $202K. The stake represents 0.03% of the portfolio and ranks #119 among its holdings. This is a return to the name: Emerald Advisors previously reported a position in MDT as recently as Q3 2021.

Emerald Advisors first reported a position in MDT in Q4 2019 and has held it in 6 quarters since. The position peaked at $552K in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Emerald Advisors held 2,335 shares of Medtronic worth $202K as of Q1 2026.
Medtronic was a new Emerald Advisors position in Q1 2026.
Medtronic made up 0.03% of Emerald Advisors's portfolio in Q1 2026, its #119 holding.
Emerald Advisors first reported a position in Medtronic in Q4 2019 and has held it in 6 quarters since.
Emerald Advisors's Medtronic position peaked at $552K in Q3 2021.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Emerald Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.